U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session.
- Abiomed, Inc. (NASDAQ: ABMD) shares surged 49.9% to settle at $377.82 on Tuesday after Johnson & Johnson announced it will acquire the company. Also, the company reported better-than-expected Q2 adjusted EPS results.
- Harsco Corporation (NYSE: HSC) climbed 22.5% to close at $6.48 after the company reported better-than-expected Q3 sales results and raised FY22 adjusted EPS guidance.
- Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) rose 14% to settle at $59.26 after the company reported better-than-expected Q3 EPS and sales results.
- Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) jumped 13.4% to settle at $15.73 after the company reported better-than-expected Q3 sales results.
- Carvana Co. (NYSE: CVNA) gained 12.9% to close at $15.28 after JP Morgan upgraded the stock from Underweight to Neutral and announced a $20 price target.
- Zai Lab Limited (NASDAQ: ZLAB) shares jumped 12.3% to close at $25.02. Shares of Chinese companies traded higher amid unconfirmed rumors suggesting a committee was exploring ways to ease China's 'Zero COVID' policy. A Chinese Foreign Ministry spokesman said he was unaware of a committee.
- Companhia Paranaense de Energia – COPEL (NYSE: ELP) gained 12.2% to settle at $7.93.
- Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) climbed 12.1% to close at $12.80 after the company posted a profit for the third quarter.
- Uber Technologies (NYSE:UBER), Inc. (NYSE: UBER) rose 12% to close at $29.75 after the company reported better-than-expected Q3 sales results and Q3 monthly active platform consumers of 124 million, up 14% year over year.
- Kanzhun Limited (NASDAQ: BZ) jumped 11.7% to close at $12.21. Shares of Chinese companies traded higher amid unconfirmed rumors suggesting a committee was exploring ways to ease China's 'Zero COVID' policy. A Chinese Foreign Ministry spokesman said he was unaware of a committee.
- H World Group Limited (NASDAQ: HTHT) shares climbed 10.8% to close at $30.00.
- Weibo Corporation (NASDAQ: WB) gained 10.1% to settle at $12.46.
- IDEXX Laboratories, Inc. (NASDAQ: IDXX) surged 9.8% to settle at $394.93 after the company reported better-than-expected Q3 EPS and sales results.
- Sony Group Corporation (NYSE: SONY) rose 9.7% to close at $74.01 after the company reported better-than-expected Q2 EPS and sales results.
- Rumble Inc. (NASDAQ: RUM) gained 9.5% to close at $13.30.
- Hologic, Inc. (NASDAQ: HOLX) rose 9.3% to close at $74.13 after the company reported better-than-expected Q3 EPS and sales results.
- Autohome Inc. (NYSE: ATHM) jumped 9% to settle at $28.46.
- Rambus Inc. (NASDAQ: RMBS) surged 8.8% to close at $32.83 following Q3 results.
- Trip.com Group Limited (NASDAQ: TCOM) shares gained 8.4% to settle at $24.54 amid unconfirmed rumors suggesting a committee was exploring ways to ease China's 'Zero COVID' policy. A Chinese Foreign Ministry spokesman said he was unaware of a committee.
- Lattice Semiconductor Corporation (NASDAQ: LSCC) gained 8.4% to close at $52.58 after the company reported better-than-expected Q3 EPS and sales results. The company also issued Q4 sales guidance above analyst estimates.
- Gartner, Inc. (NYSE: IT) jumped 7.6% to close at $325.00 after the company reported better-than-expected Q3 EPS and sales results.
- Blucora, Inc. (NASDAQ: BCOR) gained 6.1% to close at $23.37 after the company reported better-than-expected Q3 sales results and announced it sold TaxAct for $720 million in cash.
- iQIYI, Inc. (NASDAQ: IQ) rose 5.5% to close at $2.13. Shares of Chinese companies traded higher amid unconfirmed rumors suggesting a committee was exploring ways to ease China's 'Zero COVID' policy. A Chinese Foreign Ministry spokesman said he was unaware of a committee.
- Lyft (NASDAQ:LYFT), Inc. (NASDAQ: LYFT) gained 3.5% to close at $15.15 in sympathy with Uber, which reported better-than-expected Q3 sales results and Q3 monthly active platform consumers of 124 million, up 14% year over year.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.